Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZOM
9726
DELISTED
Zomedica Corp.
ZOM
| $170K | ﹤0.01% |
737,532
-393,732
| -35% | -$50.2K |
|
9727
CALL
Alta Equipment Group
ALTG
$237M
| $169K | ﹤0.01% |
17,100
+3,000
| +21% | +$25.9K |
|
9728
PUT
Energy Recovery
ERII
$426M
| $169K | ﹤0.01% |
+12,400
| New | +$132K |
|
9729
CALL
Gladstone Investment Corp
GAIN
$649M
| $169K | ﹤0.01% |
16,700
+2,800
| +20% | +$26.6K |
|
|
SVM
9730
PUT
Silvercorp Metals
SVM
$2.66B
| $169K | ﹤0.01% |
+25,200
| New | +$173K |
|
9731
Zedge
ZDGE
$38.4M
| $169K | ﹤0.01% |
28,057
+13,385
| +91% | +$46K |
|
|
AMPE
9732
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $169K | ﹤0.01% |
354
+155
| +78% | +$50.8K |
|
9733
First Trust Energy AlphaDEX Fund
FXN
$394M
| $168K | ﹤0.01% |
21,197
-433,086
| -95% | -$2.97M |
|
9734
CALL
TherapeuticsMD
TXMD
$24M
| $168K | ﹤0.01% |
2,778
-10
| -0.4% | -$683 |
|
|
TEN
9735
PUT
Tsakos Energy Navigation Ltd
TEN
$1.25B
| $168K | ﹤0.01% |
+20,900
| New | +$175K |
|
|
CIO
9736
PUT
DELISTED
City Office REIT
CIO
| $167K | ﹤0.01% |
17,100
+3,600
| +27% | +$29.6K |
|
|
CPRX
9737
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
| $167K | ﹤0.01% |
50,000
+37,800
| +310% | +$127K |
|
9738
PUT
eGain
EGAN
$206M
| $167K | ﹤0.01% |
+14,100
| New | +$199K |
|
9739
CALL
SandRidge Energy
SD
$520M
| $167K | ﹤0.01% |
53,800
+32,200
| +149% | +$79K |
|
9740
PUT
Solid Biosciences
SLDB
$986M
| $167K | ﹤0.01% |
+1,467
| New | +$92.8K |
|
|
TELL
9741
PUT
DELISTED
Tellurian Inc.
TELL
| $167K | ﹤0.01% |
130,400
+41,800
| +47% | +$47.3K |
|
|
IMGN
9742
PUT
DELISTED
Immunogen Inc
IMGN
| $167K | ﹤0.01% |
25,900
-9,700
| -27% | -$56.6K |
|
|
HLMNW
9743
DELISTED
Hillman Solutions Corp. Warrant
HLMNW
| $167K | ﹤0.01% |
+74,966
| New | +$117K |
|
|
AXDX
9744
PUT
DELISTED
Accelerate Diagnostics
AXDX
| $166K | ﹤0.01% |
2,190
-1,740
| -44% | -$156K |
|
9745
Anfield US Equity Sector Rotation ETF
AESR
$253M
| $165K | ﹤0.01% |
13,853
-54
| -0.4% | -$617 |
|
9746
CALL
Aldeyra Therapeutics
ALDX
$94.1M
| $165K | ﹤0.01% |
24,000
+600
| +3% | +$4.21K |
|
9747
Peabody Energy
BTU
$3.11B
| $165K | ﹤0.01% |
68,668
+16,845
| +33% | +$27.3K |
|
9748
PUT
Cytosorbents Corp
CTSO
$25.1M
| $165K | ﹤0.01% |
20,700
-9,900
| -32% | -$82.9K |
|
|
ZAGG
9749
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $165K | ﹤0.01% |
39,704
+21,871
| +123% | +$76.6K |
|
9750
PUT
Ardelyx
ARDX
$1.05B
| $164K | ﹤0.01% |
25,400
+2,200
| +9% | +$13.1K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.